FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Welsh Amy		 2. Date of Event Requiring Statement (MM/DD/YYYY)
11/1/2022 

 3. Issuer Name and Ticker or Trading Symbol

AGILE THERAPEUTICS INC [AGRX]
(Last)        (First)        (Middle)

500 COLLEGE ROAD EAST, SUITE 310		 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Chief Commercial Officer /
(Street)

PRINCETON,, NJ 08540      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)  (1)4/27/2030 Common Stock 1500 $95.60 D  
Employee Stock Option (Right to Buy)  (2)1/27/2031 Common Stock 1000 $112.80 D  
Employee Stock Option (Right to Buy)  (3)1/19/2032 Common Stock 1000 $13.68 D  
Explanation of Responses:
(1) This option was granted on April 27, 2020. 25% of the shares subject to the stock option vested on April 27, 2021, and the remaining shares vest in 36 equal monthly installments over the following three years, such that the option will be fully vested by April 27, 2024.
(2) This option was granted on January 27, 2021. 25% of the shares subject to the stock option vested on January 27, 2022, and the remaining shares vest in 36 monthly installments over the following three years, such that the option will be fully vested by January 27, 2025.
(3) This option was granted on January 19, 2022. 25% of the shares subject to the stock option vest on January 19, 2023, and the remaining shares vest in 36 equal monthly installments over the following three years, such that the option will be fully vested by January 19, 2026.

Remarks:
Exhibit List 24.1 - Power of Attorney

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Welsh Amy
500 COLLEGE ROAD EAST, SUITE 310
PRINCETON,, NJ 08540

Chief Commercial Officer
Signatures
/s/ Geoffrey P. Gilmore Attorney-in-Fact11/9/2022
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Agile Therapeutics Charts.
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Agile Therapeutics Charts.